Results

Total Results: 2,913 records

Showing results for "assessed".

  1. effectivehealthcare-admin.ahrq.gov/products/bipolar-disorder-treatment/research-protocol
    December 01, 2019 - quality. 15 Study-level risk of bias must be assessed using validated risk of bias tools appropriate … Systematic review quality and risk of bias will be assessed using modified AMSTAR criteria. … We will calculate MID for outcomes for which strength of evidence is assessed. … Outcomes in studies assessed as having a high risk of bias will be compared to synthesized evidence as … Attempted suicide and other self-harming behaviors will also not be assessed for strength of evidence
  2. effectivehealthcare-admin.ahrq.gov/products/c-difficile-update/research-protocol
    December 01, 2019 - In January 2014 AHRQ published a surveillance report that assessed whether an update of CER No. 31 was … Only systematic reviews that assessed and reported individual study risk of bias will be assessed for … Systematic review quality will be assessed using modified AMSTAR criteria. 33 An additional question … Were important variables known to impact the outcome(s) assessed at baseline? … Yes Who assessed outcomes?   No     Uncertain Not reported   10.
  3. effectivehealthcare-admin.ahrq.gov/products/fecal-incontinence/research-protocol
    December 01, 2019 - Although many recent systematic reviews have assessed the effectiveness of component treatments for FI … Observational studies without control groups will be included only if they assessed treatment harms ( … We plan to use relevant systematic reviews of published data that have assessed study risk of bias and … Were important variables known to impact the outcome(s) assessed at baseline? … Yes Who assessed outcomes?   No     Uncertain Not reported   10.
  4. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/genitourinary-symptoms-protocol_0.pdf
    July 10, 2023 - KQ2 RCTs or systematic review of RCTs that assessed ROB of included studies using validated tools. … KQ4 RCTs or systematic review of RCTs that assessed ROB of included studies using validated tools. … our review and assess ROB for included individual studies using appropriate validated tools will be assessed … Non-randomized trials start out as low-quality evidence, and are assessed on additional criteria (evidence … These studies will not be assessed for risk of bias, but trial characteristics will be described
  5. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/restless-legs_executive.pdf
    November 01, 2012 - We assessed treatment-related harms and adherence. … Observational studies were not formally assessed for quality. … No studies assessed treatments in pregnant women, and no eligible studies assessed treatments in patients … Few studies assessed individuals with secondary RLS. No studies enrolled pregnant women. … No RCTs assessed the effect of patient characteristics on treatment benefits and harms.
  6. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/infantile-hemangioma_executive.pdf
    January 01, 2016 - Two reviewers independently assessed the full text of each included study potentially addressing a … If one reviewer determined that a study could be eligible, we assessed its relevance to the CQs. … We assessed the SOE for the KQs only. … Most studies assessed variations of PDL (n=7) and examined heterogeneous endpoints. … Most studies assessed variations of PDL and examined heterogeneous endpoints.
  7. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/malnutrition-hospitalized-adults-protocol.pdf
    October 19, 2020 - When a study with an English abstract is published in a foreign language, the abstract will be assessed … using the Risk of Bias in Systematic Reviews (ROBIS) tool, individual RCTs will be assessed using the … Cochrane Risk of Bias 2 (ROB2) tool, and observational studies will be assessed using the Risk of Bias … Studies assessed using any of the above instruments will be rated as “Low,” “High,” or “Unclear” risk … Risk of bias will be assessed by two independent reviewers, and discrepancies will be addressed through
  8. effectivehealthcare-admin.ahrq.gov/products/malnutrition-hospitalized-adults/protocol
    December 01, 2020 - Regional or total fat mass and muscle mass assessed using validated gold standard methods, such as body … When a study with an English abstract is published in a foreign language, the abstract will be assessed … using the Risk of Bias in Systematic Reviews (ROBIS) tool, individual RCTs will be assessed using the … Cochrane Risk of Bias 2 (ROB2) tool, and observational studies will be assessed using the Risk of Bias … Studies assessed using any of the above instruments will be rated as “Low,” “High,” or “Unclear” risk
  9. effectivehealthcare-admin.ahrq.gov/products/cad-women-diagnosis-future/research
    December 01, 2019 - Eight studies assessed risk stratification and prognostic factors, two studies assessed treatment decisionmaking
  10. effectivehealthcare-admin.ahrq.gov/products/pelvic-pain/research
    March 01, 2020 - Nine studies of nonsurgical approaches assessed hormonal therapies for endometriosis-associated CPP and … Few studies assessed nonhormonal medical or nonpharmacologic management; benefits were reported in single
  11. effectivehealthcare-admin.ahrq.gov/products/calcineurin-inhibitor/research
    December 01, 2019 - We meta-analyzed data when appropriate, assessed studies for risk of bias, and evaluated the strength … Eleven studies assessed analytical performance measures.
  12. effectivehealthcare-admin.ahrq.gov/products/cad-women-diagnosis/research
    December 01, 2019 - Eight studies assessed risk stratification and prognostic factors, two studies assessed treatment decisionmaking
  13. effectivehealthcare-admin.ahrq.gov/products/infantile-hemangioma/research
    December 01, 2019 - We also assessed strength of the evidence (SOE). … Studies of steroids assessed different agents; treated children typically had improvement in lesion size
  14. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/pharma-nonpharma-ptsd-2023-update-executive-summ.pdf
    January 01, 2023 - An investigator assessed RoB for newly added studies using Cochrane’s RoB 2: A Revised Tool for Assessing … PTSD diagnostic change or clinically meaningful response were assessed in 50 percent of studies. … Among non-PTSD outcomes, depression was the most commonly assessed (60% of the newly added studies).
  15. effectivehealthcare-admin.ahrq.gov/products/disruptive-behavior-disorder/clinician
    June 01, 2021 - significant conflict with societal norms or authority figures." 4 The review included studies that assessed … The effectiveness of multicomponent programs that do not contain a parent component was not assessed … † The overall evidence grade was assessed based on the ratings for the following domains: study limitations … The drugs assessed in the studies of pharmacologic interventions were frequently used without a research
  16. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/topic-brief1-care-coordination.pdf
    April 01, 2021 - • Readmission was the main outcome of interest assessed in the reviews identified through literature … Other relevant outcomes (e.g., pain, function, quality of life, opioid utilization) were not assessed … • A cohort study of 5,749 chronic opioid users who underwent elective surgery assessed the effect … Methods We assessed the topic for suitability for further action such as commissioning a systematic … Appropriateness and Importance We assessed the nomination for appropriateness and importance, based
  17. effectivehealthcare-admin.ahrq.gov/products/genitourinary-syndrome/protocol
    March 01, 2024 - KQ2 RCTs or systematic review of RCTs that assessed ROB of included studies using validated tools. … KQ4 RCTs or systematic review of RCTs that assessed ROB of included studies using validated tools. … our review and assess ROB for included individual studies using appropriate validated tools will be assessed … Non-randomized trials start out as low-quality evidence, and are assessed on additional criteria (evidence … These studies will not be assessed for risk of bias, but trial characteristics will be described in the
  18. effectivehealthcare-admin.ahrq.gov/system/files/docs/topic-brief-hospital-length-of-stay.pdf
    November 01, 2019 - It assessed the evidence for individual components of protocols and ERAS packages. … Elsarrag et al34 assessed ERAS protocols in adults. … o A second 2018 review assessed ERAS and fast track surgery for gastrectomy. … Two SR both published in 201740, 41 assessed ERAS. … This 2018 Cochrane SR13 assessed the evidence for short-stay units.
  19. effectivehealthcare-admin.ahrq.gov/products/peripheral-artery-disease-treatment/research
    December 01, 2019 - This review assessed the comparative effectiveness of antiplatelet therapy, medical therapy, exercise … Four additional studies assessed other antiplatelet comparisons but were too small to make any meaningful
  20. effectivehealthcare-admin.ahrq.gov/products/asd-interventions/research-2017
    January 01, 2021 - We also assessed strength of the evidence (SOE). … Populations, intervention approaches, and outcomes assessed varied across studies.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: